Cargando…

COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential

BACKGROUND: Coronavirus disease 2019 (COVID-19) is posing a huge threat to human health worldwide. We aim to investigate the immune status of CD8(+) T and NK cells in COVID-19 patients. METHODS: The count and immune status of lymphocytes were detected by flow cytometry in 32 COVID-19 patients and 18...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yujie, Wei, Xin, Guan, Jingjing, Qin, Shuang, Wang, Zhongyong, Lu, Hong, Qian, Jingjing, Wu, Lianfeng, Chen, Yingxiao, Chen, Yanfan, Lin, Xiangyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305921/
https://www.ncbi.nlm.nih.gov/pubmed/32574709
http://dx.doi.org/10.1016/j.clim.2020.108516
_version_ 1783548566444179456
author Jiang, Yujie
Wei, Xin
Guan, Jingjing
Qin, Shuang
Wang, Zhongyong
Lu, Hong
Qian, Jingjing
Wu, Lianfeng
Chen, Yingxiao
Chen, Yanfan
Lin, Xiangyang
author_facet Jiang, Yujie
Wei, Xin
Guan, Jingjing
Qin, Shuang
Wang, Zhongyong
Lu, Hong
Qian, Jingjing
Wu, Lianfeng
Chen, Yingxiao
Chen, Yanfan
Lin, Xiangyang
author_sort Jiang, Yujie
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) is posing a huge threat to human health worldwide. We aim to investigate the immune status of CD8(+) T and NK cells in COVID-19 patients. METHODS: The count and immune status of lymphocytes were detected by flow cytometry in 32 COVID-19 patients and 18 healthy individuals. RESULTS: As the disease progression in COVID-19 patients, CD8(+) T and NK cells were significantly decreased in absolute number but highly activated. After patients' condition improved, the count and immune status of CD8(+) T and NK cells restored to some extent. GrA(+)CD8(+) T and perforin(+) NK cells had good sensitivity and specificity for assisting diagnosis of COVID-19. CONCLUSIONS: As the disease progression, the declined lymphocytes in COVID-19 patients might lead to compensatory activation of CD8(+) T and NK cells. GrA(+)CD8(+) T and perforin(+) NK cells might be used as meaningful indicators for assisting diagnosis of COVID-19.
format Online
Article
Text
id pubmed-7305921
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-73059212020-06-22 COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential Jiang, Yujie Wei, Xin Guan, Jingjing Qin, Shuang Wang, Zhongyong Lu, Hong Qian, Jingjing Wu, Lianfeng Chen, Yingxiao Chen, Yanfan Lin, Xiangyang Clin Immunol Article BACKGROUND: Coronavirus disease 2019 (COVID-19) is posing a huge threat to human health worldwide. We aim to investigate the immune status of CD8(+) T and NK cells in COVID-19 patients. METHODS: The count and immune status of lymphocytes were detected by flow cytometry in 32 COVID-19 patients and 18 healthy individuals. RESULTS: As the disease progression in COVID-19 patients, CD8(+) T and NK cells were significantly decreased in absolute number but highly activated. After patients' condition improved, the count and immune status of CD8(+) T and NK cells restored to some extent. GrA(+)CD8(+) T and perforin(+) NK cells had good sensitivity and specificity for assisting diagnosis of COVID-19. CONCLUSIONS: As the disease progression, the declined lymphocytes in COVID-19 patients might lead to compensatory activation of CD8(+) T and NK cells. GrA(+)CD8(+) T and perforin(+) NK cells might be used as meaningful indicators for assisting diagnosis of COVID-19. Published by Elsevier Inc. 2020-09 2020-06-20 /pmc/articles/PMC7305921/ /pubmed/32574709 http://dx.doi.org/10.1016/j.clim.2020.108516 Text en © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jiang, Yujie
Wei, Xin
Guan, Jingjing
Qin, Shuang
Wang, Zhongyong
Lu, Hong
Qian, Jingjing
Wu, Lianfeng
Chen, Yingxiao
Chen, Yanfan
Lin, Xiangyang
COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential
title COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential
title_full COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential
title_fullStr COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential
title_full_unstemmed COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential
title_short COVID-19 pneumonia: CD8(+) T and NK cells are decreased in number but compensatory increased in cytotoxic potential
title_sort covid-19 pneumonia: cd8(+) t and nk cells are decreased in number but compensatory increased in cytotoxic potential
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305921/
https://www.ncbi.nlm.nih.gov/pubmed/32574709
http://dx.doi.org/10.1016/j.clim.2020.108516
work_keys_str_mv AT jiangyujie covid19pneumoniacd8tandnkcellsaredecreasedinnumberbutcompensatoryincreasedincytotoxicpotential
AT weixin covid19pneumoniacd8tandnkcellsaredecreasedinnumberbutcompensatoryincreasedincytotoxicpotential
AT guanjingjing covid19pneumoniacd8tandnkcellsaredecreasedinnumberbutcompensatoryincreasedincytotoxicpotential
AT qinshuang covid19pneumoniacd8tandnkcellsaredecreasedinnumberbutcompensatoryincreasedincytotoxicpotential
AT wangzhongyong covid19pneumoniacd8tandnkcellsaredecreasedinnumberbutcompensatoryincreasedincytotoxicpotential
AT luhong covid19pneumoniacd8tandnkcellsaredecreasedinnumberbutcompensatoryincreasedincytotoxicpotential
AT qianjingjing covid19pneumoniacd8tandnkcellsaredecreasedinnumberbutcompensatoryincreasedincytotoxicpotential
AT wulianfeng covid19pneumoniacd8tandnkcellsaredecreasedinnumberbutcompensatoryincreasedincytotoxicpotential
AT chenyingxiao covid19pneumoniacd8tandnkcellsaredecreasedinnumberbutcompensatoryincreasedincytotoxicpotential
AT chenyanfan covid19pneumoniacd8tandnkcellsaredecreasedinnumberbutcompensatoryincreasedincytotoxicpotential
AT linxiangyang covid19pneumoniacd8tandnkcellsaredecreasedinnumberbutcompensatoryincreasedincytotoxicpotential